Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GNA12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ADD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GGT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
TMTC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDCD6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DUSP14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HARS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PI4KA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP2R1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UFC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF343 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIFAP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HDAC4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2D3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on